Characterization of adhesion receptors on cultured microvascular endothelial cells derived from the retroorbital connective tissue of patients with Graves' ophthalmopathy

European Journal of Endocrinology

Volumn 134, Issue 1, 1996, Pages 51-60

  Heufelder, Armin E ^a   Scriba, Peter C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

EID: 0030025044     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340051     Document Type: Article

References (30)

1. Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 1991;388:25-32
2. Bahn RS. Heufelder AE. Mechanisms of disease: pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993;329:1468-75
3. Gorman CA, Heufelder AE, Bartley GB, Ophthalmopathy. In: DeGroot LJ, editor. Endocrinology. 3rd ed. Philadelphia: WB Saunders. 1994:712-25
4. Hufnagel TJ. Hickey WF. Cobbs WH. Jacobiec FA. Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984;91:1411-9
5. Weetman AP, Cohen S, Gatter KC, Fells D, Shine B, Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989;75:222-7
6. Heufelder AE, Bahn RS, Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993;23:10-7
7. Heufelder AE, Bahn RS, Elevated expression in situ of selectin and immunoglobulin superfamily adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy. Clin Exp Immunol 1993;91:381-9
8. Heufelder AE, Bahn RS, Soluble intercellular adhesion molecule-I (ICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases. Clin Exp Immunol 1993;92:296-302
9. Heufelder AE, Bahn RS, Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest 1992;22:529-37
10. Bahn RS, Heufelder AE, Retroocular fibroblasts: important effector cells in Graves' opthalmopathy. Thyroid 1992;2:89-94
11. Burch HB, Wartofsky L, Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993;14:747-93
12. Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G, Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8- and specifically recognize autologous fibroblasts. J Clin Invest 1994;93:2738-43
13. de Carli M, D'Elios M, Mariotti S, Marcocci C, Pinchera A, Ricci M, et al. Cytolytic T cells with Th-1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab 1993;77:1120-4
14. Carlos TM, Harlan JM, Leucocyte-endothelial adhesion molecules. Blood 1994;84:2068-101
15. Todd I, Pujol-Borrell R, Hammond L, Bottazzo GF, Feldmann M, Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985;61:265-73
16. Heufelder AE, Bahn RS, Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. Invest Ophthalmol Vis Sci 1994;35:120-7
17. Heufelder AE, Herterich S, Ernst G, Bahn RS, Scriba PC, Analysis of retroorbital T cell antigen receptor variable region gene usage repertoire in patients with Graves' ophthalmopathy. Eur J Endocrinol 1995;132:266-77
18. Heufelder AE. Pathogenesis of Graves' ophthalmopathy: recent controversies and progress. Eur J Endocrinol 1995;132:532-41
19. Heufelder AE. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy. Thyroid 1995;5:331-40
20. Miyake K, Underhill CB, Lesley J, Kinkade PW, Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75
21. Aruffo A, Stamencovic I. Meinich M, Underhill CB, Seed B, CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1301-13
22. Rosenman S, St John T, CD44. In: Kreis T, Valeem R, editors. Guidebook to the extracellular matrix and adhesion proteins. Oxford: Oxford University Press, 1993:27-9
23. Lesley. J, Hyman R, CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 1992;22:2719-23
24. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW, Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med 1992: 175:257-66
25. Bruynzeel I, Koopman G, van der Raaji LMH, Pals ST. Willemze R. CD44 antibody stimulates adhesion of peripheral blood T cells to keratinocytes through the leucocyte function-associated antigen1/intercellular adhesion molecule-1 pathway. J Invest Dermatol 1993;100:424-8
26. Heufelder AE, Bahn RS, Boergen KP, Scriba PC, Nachweis. Lokalisation und Modulation der CD44/Hyaluronsäure-Rezeptor-Expression bei Patienten mit endokriner Orbitopathie. Med Klin 1993;88:181-5
27. Marazuela M. Postigo AA. Acevedo A. Biaz-Gonzalez F. Sanchez-Madrid F, de Landazuri MO, Adhesion molecules from the LFA/ ICAM-1.3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. Eur J Immunol 1994;24.2483-90
28. Marlor CW, Webb DL, Bombara MP, Greve JM, Blue ML, Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor. Am J Pathol 1992;140:1055-60
29. 1 integrin (VLA-4) hgands in arthritis. J Immunol 1992;149:1424-31
30. Makgoba MW, Bernard A, Sanders ME, Cell adhesion/signalling: biology and clinical applications. Eur J Clin Invest 1992;22:443-53